Rankings
▼
Calendar
NAGE FY 2020 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$59M
+28.0% YoY
Gross Profit
$35M
59.5% margin
Operating Income
-$20M
-33.5% margin
Net Income
-$20M
-33.6% margin
EPS (Diluted)
$-0.33
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$38M
Total Liabilities
$22M
Stockholders' Equity
$16M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$59M
$46M
+28.0%
Gross Profit
$35M
$26M
+36.9%
Operating Income
-$20M
-$31M
+36.6%
Net Income
-$20M
-$32M
+38.0%
← Q4 2019
All Quarters
Q1 2020 →